Learn More
Bachem Astressin Trifluoroacetate

Supplier: Bachem 4026664.0500
Astressin Trifluoroacetate, H-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(-Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2, 170809-51-5, C161H269N49O42, Mr 3563.24, 0.5mg. (D-Phe12,Nle21·38,cyclo(Glu30-Lys33))-CRF (12-41) (human, rat). The Glu30 to Lys33 lactam bridge constrains astressin in an a-helical conformation which seems to be responsible for its especially high CRF antagonist activity. Astressin is 100 times more potent than a-helical CRF (9-41) at inhibiting ACTH secretion in vitro, and more than 10 times more potent in vivo than any other CRF antagonist reported to date.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.